HSPB7 Deficiency Drives Aortic Aneurysm Progression in Marfan Syndrome Through Vascular Smooth Muscle Cell Phenotypic Switching
Clinical and Experimental Pharmacology and Physiology · 2026-06 · 53 (6)
DOI: 10.1111/1440-1681.70128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 27.05.2026. Verfasst von Zining An und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Marfan Syndrome, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, HSP27 Heat-Shock Proteins. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Research Plan of SHDC, Jiangsu Joint Project of Ili and Jiangsu Joint Institute of Health.
Abstract (Originalsprache)
Marfan syndrome (Mfs) arises from mutations in FBN1, predisposing individuals to thoracic aortic aneurysm (TAA) through abnormal smooth muscle cell behaviour. The role of HSPB7 in Mfs‐related TAA remains poorly understood. By integrating multi‐omics analysis with hiPSC‐derived VSMCs from patients with Mfs, we elucidated the molecular landscape of Mfs‐associated TAA. Analysis revealed immune cell infiltration, a reduced proportion of VSMCs, and altered intercellular communication. Pathway analyses indicated changes in cell adhesion, extracellular matrix (ECM) remodelling, and immune signalling, with downregulated metabolic pathways. Findings suggest structural, immune, and metabolic imbalances in Mfs‐TAA pathogenesis. Downregulation of HSPB7 was associated with altered proliferation, migration, and metabolic activity. Overexpression of HSPB7 in patient‐specific hiPSC‐derived VSMCs attenuated these pathological features and promoted a more contractile phenotype. These findings suggest that HSPB7 may be involved in the regulation of VSMCs' phenotypic modulation in Mfs‐TAA and provide mechanistic insight into disease‐associated cellular alterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- Clinical Research Plan of SHDC
- Jiangsu Joint Project of Ili and Jiangsu Joint Institute of Health
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Key Specialty Construction Project 2024
- Jiangsu Province Capability Improvement Project through Science, Technology and Education
Zitieren
APA
An, Z., Yan, T., Ming, Y., Tang, Z., Yang, Z., Zhang, H., Zhu, K., & Shao, Y. (2026). HSPB7 Deficiency Drives Aortic Aneurysm Progression in Marfan Syndrome Through Vascular Smooth Muscle Cell Phenotypic Switching. Clinical and Experimental Pharmacology and Physiology, 53(6). https://doi.org/10.1111/1440-1681.70128
Vancouver
An Z, Yan T, Ming Y, Tang Z, Yang Z, Zhang H, et al. HSPB7 Deficiency Drives Aortic Aneurysm Progression in Marfan Syndrome Through Vascular Smooth Muscle Cell Phenotypic Switching. Clinical and Experimental Pharmacology and Physiology. 2026;53(6). doi:10.1111/1440-1681.70128
BibTeX
@article{An2026,
author = {An, Zining and Yan, Tao and Ming, Yang and Tang, Zhiwei and Yang, Zhaohua and Zhang, Hui and Zhu, Kai and Shao, Yongfeng},
title = {HSPB7 Deficiency Drives Aortic Aneurysm Progression in Marfan Syndrome Through Vascular Smooth Muscle Cell Phenotypic Switching},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2026},
volume = {53},
number = {6},
doi = {10.1111/1440-1681.70128}
}
EUVIMED